Jerome D. Goldberg

Array ( [id] => 3457589 [patent_doc_number] => 05401774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-28 [patent_title] => 'Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds' [patent_app_type] => 1 [patent_app_number] => 7/839203 [patent_app_country] => US [patent_app_date] => 1992-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12406 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/401/05401774.pdf [firstpage_image] =>[orig_patent_app_number] => 839203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406734 [patent_doc_number] => 06271242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Method for treating cancer using a tyrosine protein kinase inhibitor' [patent_app_type] => 1 [patent_app_number] => 7/834065 [patent_app_country] => US [patent_app_date] => 1992-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6793 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271242.pdf [firstpage_image] =>[orig_patent_app_number] => 834065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2931467 [patent_doc_number] => 05219846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Treatment of human tumors utilizing compounds having a phosphoamides linkage or enol phosphate linkage' [patent_app_type] => 1 [patent_app_number] => 7/811058 [patent_app_country] => US [patent_app_date] => 1991-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1649 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219846.pdf [firstpage_image] =>[orig_patent_app_number] => 811058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2915359 [patent_doc_number] => 05234698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-10 [patent_title] => 'Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate' [patent_app_type] => 1 [patent_app_number] => 7/802606 [patent_app_country] => US [patent_app_date] => 1991-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8243 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/234/05234698.pdf [firstpage_image] =>[orig_patent_app_number] => 802606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2980388 [patent_doc_number] => 05204367 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-20 [patent_title] => 'Novel antiviral and anti-leukemia terpene hydroquinones and methods of use' [patent_app_type] => 1 [patent_app_number] => 7/803255 [patent_app_country] => US [patent_app_date] => 1991-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4515 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/204/05204367.pdf [firstpage_image] =>[orig_patent_app_number] => 803255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2953718 [patent_doc_number] => 05242921 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-07 [patent_title] => 'Compositions and methods for treating cutaneous hyperproliferative disorders' [patent_app_type] => 1 [patent_app_number] => 7/783560 [patent_app_country] => US [patent_app_date] => 1991-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4205 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/242/05242921.pdf [firstpage_image] =>[orig_patent_app_number] => 783560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3062945 [patent_doc_number] => 05310762 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-10 [patent_title] => 'Medicaments' [patent_app_type] => 1 [patent_app_number] => 7/796324 [patent_app_country] => US [patent_app_date] => 1991-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7984 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/310/05310762.pdf [firstpage_image] =>[orig_patent_app_number] => 796324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3092268 [patent_doc_number] => 05312833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-17 [patent_title] => 'Method of inhibiting tumor growth using xanthocillin X dimethylether' [patent_app_type] => 1 [patent_app_number] => 7/792993 [patent_app_country] => US [patent_app_date] => 1991-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1546 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/312/05312833.pdf [firstpage_image] =>[orig_patent_app_number] => 792993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3096335 [patent_doc_number] => 05318979 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-07 [patent_title] => 'Method of inhibiting the activity of cryptosporidium parvum' [patent_app_type] => 1 [patent_app_number] => 7/794614 [patent_app_country] => US [patent_app_date] => 1991-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4526 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/318/05318979.pdf [firstpage_image] =>[orig_patent_app_number] => 794614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2891996 [patent_doc_number] => 05270320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-14 [patent_title] => 'Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridi ne for the manufacture of a medicament for the treatment of cerebral and neuronal diseases' [patent_app_type] => 1 [patent_app_number] => 7/789044 [patent_app_country] => US [patent_app_date] => 1991-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3886 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/270/05270320.pdf [firstpage_image] =>[orig_patent_app_number] => 789044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3108549 [patent_doc_number] => 05407925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-18 [patent_title] => 'Regional chemotherapy within the central nervous system with 4-hydroperoxycyclophosphamide' [patent_app_type] => 1 [patent_app_number] => 7/788609 [patent_app_country] => US [patent_app_date] => 1991-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2405 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/407/05407925.pdf [firstpage_image] =>[orig_patent_app_number] => 788609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2806110 [patent_doc_number] => 05157049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-20 [patent_title] => 'Method of treating cancers sensitive to treatment with water soluble derivatives of taxol' [patent_app_type] => 1 [patent_app_number] => 7/784624 [patent_app_country] => US [patent_app_date] => 1991-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4290 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/157/05157049.pdf [firstpage_image] =>[orig_patent_app_number] => 784624 [rel_patent_id] =>[rel_patent_doc_number] =>)